Agilent Technologies, Inc. (NYSE:A) Stock Rated “Moderate Buy” by Wall Street Analysts

Shares of Agilent Technologies, Inc. (NYSE:A) have been given an average recommendation of “Moderate Buy” by the nineteen analysts that are currently covering the firm, MarketBeat.com reports. Four investment analysts have rated the stock with a hold rating and fifteen have issued a buy rating on the company. The average twelve-month target price among analysts that have issued ratings on the stock in the last year is $173.65.

Several brokerages have recently weighed in on A. Weiss Ratings raised Agilent Technologies from a “hold (c+)” rating to a “buy (b-)” rating in a report on Thursday, October 8th. Stifel Nicolaus upped their target price on Agilent Technologies from $170.00 to $180.00 and gave the company a “buy” rating in a research note on Thursday, August 27th. Morgan Stanley raised their target price on Agilent Technologies from $175.00 to $190.00 and gave the stock an “overweight” rating in a research report on Tuesday, October 13th. Royal Bank Of Canada raised their target price on Agilent Technologies from $155.00 to $185.00 and gave the stock an “outperform” rating in a research report on Thursday, August 27th. Finally, Barclays lifted their price target on shares of Agilent Technologies from $175.00 to $195.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 7th.

Insider Activity

In other news, Director Mikael Dolsten sold 634 shares of the firm’s stock in a transaction dated Friday, September 4th. The shares were sold at an average price of $151.38, for a total transaction of $95,974.92. Following the completion of the transaction, the director directly owned 4,924 shares of the company’s stock, valued at approximately $745,395.12. This trade represents a 11.41% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website.

Institutional Trading of Agilent Technologies

Several institutional investors have recently made changes to their positions in A. Integrated Advisors Network LLC lifted its stake in Agilent Technologies by 2.2% during the third quarter. Integrated Advisors Network LLC now owns 3,442 shares of the medical research company’s stock worth $593,000 after purchasing an additional 75 shares during the period. Robeco Institutional Asset Management B.V. boosted its holdings in Agilent Technologies by 89.7% during the third quarter. Robeco Institutional Asset Management B.V. now owns 558,144 shares of the medical research company’s stock valued at $96,174,000 after purchasing an additional 263,871 shares in the last quarter. 55 North Private Wealth LLC boosted its holdings in Agilent Technologies by 4.9% during the third quarter. 55 North Private Wealth LLC now owns 1,658 shares of the medical research company’s stock valued at $286,000 after purchasing an additional 78 shares in the last quarter. Investment Research Partners LLC grew its stake in shares of Agilent Technologies by 1.8% in the 3rd quarter. Investment Research Partners LLC now owns 3,646 shares of the medical research company’s stock valued at $628,000 after purchasing an additional 63 shares during the period. Finally, Maia Wealth LLC bought a new stake in shares of Agilent Technologies in the 3rd quarter valued at approximately $212,000.

Agilent Technologies Stock Up 1.9%

NYSE A opened at $173.09 on Wednesday. Agilent Technologies has a twelve month low of $108.35 and a twelve month high of $177.47. The stock has a market cap of $48.80 billion, a PE ratio of 34.07, a PEG ratio of 2.59 and a beta of 1.21. The firm has a 50-day simple moving average of $159.90 and a 200 day simple moving average of $138.53. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.56 and a current ratio of 2.05.

Agilent Technologies (NYSE:A) last issued its quarterly earnings results on Wednesday, August 26th. The medical research company reported $1.62 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.49 by $0.13. Agilent Technologies had a return on equity of 24.45% and a net margin of 19.53%. The firm had revenue of $1.88 billion for the quarter, compared to analyst estimates of $1.84 billion. During the same period in the previous year, the company posted $1.37 earnings per share. The company’s quarterly revenue was up 8.1% compared to the same quarter last year. Agilent Technologies has set its Q4 2026 guidance at 1.710-1.740 EPS and its FY 2026 guidance at 6.180-6.210 EPS. On average, research analysts forecast that Agilent Technologies will post 6.20 EPS for the current year.

Agilent Technologies Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 28th. Stockholders of record on Tuesday, October 6th will be paid a $0.2550 dividend. The ex-dividend date is Tuesday, October 6th. This represents a $1.02 dividend on an annualized basis and a dividend yield of 0.6%. Agilent Technologies’s dividend payout ratio is currently 20.08%.

About Agilent Technologies

Agilent Technologies, Inc is a global provider of analytical laboratory instruments, software, services and consumables. The company serves customers in the pharmaceutical, biotechnology, chemical, food, environmental, energy and academic research sectors, as well as diagnostic and clinical laboratories.

Agilent’s offerings include liquid and gas chromatography systems, mass spectrometry instruments, spectroscopy and atomic instruments, laboratory automation products, genomic and cell analysis solutions, and related software.